Review
Published on 31 Oct 2022
Synthetic approaches to potent heterocyclic inhibitors of tuberculosis: A decade review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1021216
- 3,159 views
- 5 citations
Type at least 3 characters
316 articles
Articles
Original Research
Published on 25 Oct 2022
Berberine prevents lethal EV71 neurological infection in newborn mice
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1027566
- 3,169 views
- 9 citations
Review
Published on 21 Oct 2022
Polyphenolic promiscuity, inflammation-coupled selectivity: Whether PAINs filters mask an antiviral asset
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.909945
- 3,526 views
- 10 citations
Original Research
Published on 20 Oct 2022
Genotype-phenotype association and biochemical analyses of glucose-6-phosphate dehydrogenase variants: Implications for the hemolytic risk of using 8-aminoquinolines for radical cure
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1032938
- 2,482 views
- 3 citations
Original Research
Published on 18 Oct 2022
Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1024608
- 2,036 views
Original Research
Published on 14 Oct 2022
Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1023704
- 2,599 views
- 3 citations
Brief Research Report
Published on 14 Oct 2022
Antimicrobial and anti-inflammatory effects of Eugenia brejoensis essential oil in mice wounds infected by Staphylococcus aureus
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.999131
- 2,314 views
- 7 citations
Systematic Review
Published on 13 Oct 2022
Terpenes as bacterial efflux pump inhibitors: A systematic review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.953982
- 8,106 views
- 26 citations
Original Research
Published on 10 Oct 2022
The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1001924
- 2,136 views
- 2 citations
Editorial
Published on 06 Oct 2022
Editorial: Women in pharmacology of infectious diseases: 2021
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1038369
- 1,116 views
Systematic Review
Published on 06 Oct 2022
Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: An updated meta-analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.938419
- 3,872 views
- 8 citations
Original Research
Published on 30 Sep 2022
Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1020123
- 2,735 views
- 3 citations
Systematic Review
Published on 28 Sep 2022
The efficacy and adverse events of delafloxacin in the treatment of acute bacterial infections: A systematic review and meta-analysis of randomized controlled trials
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.975578
- 3,297 views
- 3 citations
Original Research
Published on 26 Sep 2022
Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.982981
- 3,361 views
- 7 citations
Original Research
Published on 26 Sep 2022
Antimicrobial activity of natural products against MDR bacteria: A scientometric visualization analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1000974
- 4,844 views
- 6 citations
Original Research
Published on 26 Sep 2022
Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2022.907921
- 2,373 views
- 5 citations